RxNorm Semantic Concepts Index - 292
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "292".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 29201 | Maleylacetate reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29201 | Maleylacetate reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29202 | Maleylacetoacetate isomerase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29202 | Maleylacetoacetate isomerase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 292036 | indanazoline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 29209 | malic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2921 | cromoglycate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 29216 | Malonate-semialdehyde dehydrogenase (acetylating) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29216 | Malonate-semialdehyde dehydrogenase (acetylating) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2922 | Flurogestone acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2922 | Flurogestone acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29220 | Malonyl-CoA decarboxylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29220 | Malonyl-CoA decarboxylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29235 | Maltose phosphorylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29235 | Maltose phosphorylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29236 | MTP | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29236 | MTP | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29236 | MTP | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29245 | Malyl-coenzyme A lyase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29245 | Malyl-coenzyme A lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29245 | Malyl-coenzyme A lyase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29246 | Malyl-CoA synthetase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29246 | Malyl-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29246 | Malyl-CoA synthetase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29246 | Malyl-CoA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29255 | Mandelate racemase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29255 | Mandelate racemase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29256 | mandelic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 29256 | mandelic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29256 | mandelic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29256 | mandelic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29256 | mandelic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29256 | mandelic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29256 | mandelic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29257 | Hydroxynitrile lyase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29257 | Hydroxynitrile lyase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29257 | Hydroxynitrile lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29257 | Hydroxynitrile lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29257 | Hydroxynitrile lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2926 | Pit viper venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2926 | Pit viper venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29261 | manganese chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 29261 | manganese chloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29261 | manganese chloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29261 | manganese chloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 29261 | manganese chloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 29263 | manganese dioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 29266 | Manganese peroxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29266 | Manganese peroxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29268 | manganese sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 292726 | phenylhydrazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 29275 | manidipine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 29275 | manidipine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29275 | manidipine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29278 | Exo-1,2-1,3-alpha-mannosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29278 | Exo-1,2-1,3-alpha-mannosidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29278 | Exo-1,2-1,3-alpha-mannosidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29280 | Mannose-binding lectin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 29280 | Mannose-binding lectin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29280 | Mannose-binding lectin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29284 | Mannitol-1-phosphatase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29284 | Mannitol-1-phosphatase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29286 | Mannitol-1-phosphate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29286 | Mannitol-1-phosphate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29290 | Mannokinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29290 | Mannokinase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 29292 | Mannonate dehydratase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 29292 | Mannonate dehydratase | Full form of descriptor (FN) | NO |